Showing results (131-140 of 2,036) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|October 1, 1977
[Nuclear medicine examination procedures in the supervision of renal transplant patients]M W Strötgen, G Schmitt, H G HartmannNuklearmedizin. Nuclear Medicine|December 1, 1989
3,5,3'-Triiodothyroacetic acid (TRIAC) effects on pituitary thyroid regulation and on peripheral tissue parametersP Lind, W Langsteger, P Költringer, et al.Nuklearmedizin. Nuclear Medicine|December 1, 1989
[Anemia in malignant tumor diseases. II. Tumor-induced loss of transferrin as a cause of the development of anemia based on a rat model]E AulbertNuklearmedizin. Nuclear Medicine|July 23, 2016
Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world studyRogier Lange, Floor Overbeek, John M H de Klerk, et al.Nuklearmedizin. Nuclear Medicine|April 8, 2020
Textural features in FDG-PET/CT can predict outcome in melanoma patients to treatment with Vemurafenib and IpililumabDaniela Dittrich, Thomas Pyka, Klemens Scheidhauer, et al.Nuklearmedizin. Nuclear Medicine|February 1, 1983
Should treatment of highly differentiated thyroid carcinoma be conservative?H J Biersack, B Helpap, U Koch, et al.Nuklearmedizin. Nuclear Medicine|October 25, 2019
Myocardial Perfusion SPECT 2018 in Germany: Results of the 8th SurveyOliver Lindner, Wolfgang Burchert, Ronny Buechel, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1981
Quality control of dose calibratorsA N Jain, M A RehmanNuklearmedizin. Nuclear Medicine|December 1, 1984
The use of autologous 111In-labelled platelets and scintigraphy to illustrate enhanced platelet activity during erection in the chacma baboonI C Dormehl, M S Bornman, D J du Plessis, et al.Nuklearmedizin. Nuclear Medicine|June 1, 1984
[Modification of the FT4-level and the nonspecific peripheral thyroid parameter by heparin]B Eber, J Borkenstein, G LebPageof 204